UTI-I is likely to sell its stake in the ongoing open offer of Standard & Poor. It is currently in the midst of submitting a report to the government on sales of strategic holdings, sources in UTI-I said.

Sources indicate that UTI-I's exit from Crisil can also trigger its exit from other sensitive companies such as Icra and CARE, where UTI-I holds 7.95 per cent and 12.5 per cent respectively.

UTI-I's holding in 8-9 sensitive companies is valued around at Rs 6,500-7,000 crore (Rs 65 to 70 billion). UTI-I needs prior government approval to sell stake in these companies.

A senior UTI-I official said the revised S&P offer for Crisil was a fair price to exit. The government has already indicated to financial institutions to take a commercial decision regarding selling their stake in Crisil and the submission of the proposed report was a mere formality, the official added.

The Unit Trust of India house holds a 8.43 per cent stake in Crisil, with UTI-I holding a 4 per cent stake while the rest is with the UTI Mutual Fund.

Both UTI-I and UTI-MF are likely to participate in the open offer, which could fetch them Rs 41.46 crore (Rs 414.6 billion) at the current offer price of Rs 775 a share.